Constante, Marco

Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis

Galipeau, H. J., Caminero, A., Turpin, W., Bermudez-Brito, M., Santiago, A., Libertucci, J., Constante, M., Raygoza Garay, J. A., Rueda, G., Armstrong, S., et al. (2021) · Gastroenterology

Gut microbiota and healthInflammatory Bowel Disease

Cited by 190

Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation

Lamas, B., Hernandez-Galan, L., Galipeau, H. J., Constante, M., Clarizio, A., Jury, J., Breyner, N. M., Caminero, A., Rueda, G., Hayes, C. L., et al. (2020) · Science Translational Medicine

Celiac Disease Research and ManagementGut microbiota and health

Cited by 179

Dietary heme induces gut dysbiosis, aggravates colitis, and potentiates the development of adenomas in mice

Constante, M., Fragoso, G., Calvé, A., Samba-Mondonga, M., & Santos, M. M. (2017) · Frontiers in Microbiology

Gut microbiota and healthInflammatory Bowel Disease

Cited by 161

Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2

Caminero, A., McCarville, J. L., Galipeau, H. J., Deraison, C., Bernier, S. P., Constante, M., Rolland, C., Meisel, M., Murray, J. A., Yu, X. B., et al. (2019) · Nature Communications

Celiac Disease Research and ManagementGut microbiota and health

Cited by 139